Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-26 @ 2:27 PM
Study NCT ID:
NCT04465292
Status:
UNKNOWN
Last Update Posted:
2020-07-10
First Post:
2020-05-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
Sponsor:
Brigham and Women's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-14
First Submit QC Date:
None
Study First Post Date:
2020-07-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-06
Last Update Post Date:
2020-07-10
Last Update Post Date Type:
ACTUAL